Immediate Impact

3 by Nobel laureates 4 from Science/Nature 70 standout
Sub-graph 1 of 23

Citing Papers

mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Accelerating antiviral drug discovery: lessons from COVID-19
2023 Standout
1 intermediate paper

Works of Dereck Tait being referenced

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein
2019
Innovative clinical trial designs to rationalize TB vaccine development
2015

Author Peers

Author Last Decade Papers Cites
Dereck Tait 573 312 128 22 900
Eithne MacMahon 585 323 166 39 1.0k
Judy Zeh 906 323 83 11 1.1k
R W Cone 768 251 105 18 1.1k
Sharon G. Paryani 508 192 55 17 785
R. Berger 741 210 162 44 1.1k
Jerome Kopelman 527 225 52 52 1.1k
Theresia Popow‐Kraupp 783 318 134 45 1.1k
Karen E. Mark 567 173 189 19 777
Mauricio Vargas‐Cortes 691 177 249 17 952
M. Dillon 476 290 96 14 742

All Works

Loading papers...

Rankless by CCL
2026